Investigating whether androgen-induced ADAM10 upregulation shifts APP processing toward sAPPα production and how this affects cancer biology will be critical for determining whether targeting and enhancing ADAM10 could serve as a therapeutic strategy for cancer. Here, APP is linked to cancer.